慧聰集團(02280.HK)分拆北京兆信 將以後續詢價作為發行底價
慧聰集團(02280.HK)公布,非全資附屬北京兆信在北京證券交易所上市,於提交上市申請時,按北京證券交易所當時的上市規則及慣例,提前確定的發行底價為每股6.5元人民幣,最終發行價由北京兆信董事會及主承銷商,根據詢價結果,並考慮市場情況等因素後釐定。
其後中證監提出意見,要求改革發行底價制度,新舉措包括北京證券交易所不再要求發行人,於提交上市申請時,提前確定發行底價。北京兆信董事會已相應決議,將以後續詢價或定價結果作為發行底價,取代上述提前確定的發行底價。
公司提醒投資者,最終發行價尚未釐定,最終發行價及發行規模將於建議接近完成階段才會釐定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.